The influence of non-alcoholic fatty liver disease on the state of the macrophagal phagocytosis system in patients with community-acquired pneumonia.
DOI:
https://doi.org/10.26641/2307-0404.2018.1(part1).127250Keywords:
community-acquired pneumonia, fatty liver disease, hepatic steatosis, macrophage phagocyted systemAbstract
More and more attention of researchers is attracted by the so-called "syndrome of mutual burdening" in combined (comorbid) pathology. The aim of the study was to analyze the effect of nonalcoholic fatty liver disease on the functional state of the macrophagal phagocytic system (MPS) in patients with community-acquired pneumonia (CAP). 85 patients with CAP of III-IV clinical group aged 18-55 years were examined. All patients were divided into two representative groups: group I (44 patients) who had CAP comorbid with hepatic steatosis (HS), group ІІ (41 patients) without chronic liver pathology. For evaluation of the functional activity of MPS, phagocytic activity of peripheral blood monocytes with analysis of phagocytic index (FI), phagocytic number (FN), index of attraction (IA) and index of digestion (ID) was studied. The results of the study revealed that in the acute period of CAP, more expressed decrease in the capacity of monocytes/macrophages to phagocytosis, the incompleteness of the phagocytic reaction, and in general, the decline in the functional activity of MPS was observed in patients with CAP comorbid with HS. After the completion of the standard treatment of patients with CAP combined with HS, moderate disturbances in the functional activity of MPS persisted. On the assumption of findings, it can be advisable to consider a further study of the effectiveness of immunotropic medicines usage, with the purpose of correcting MPS disturbances in the complex treatment and medical rehabilitation of patients with CAP comorbid with HS.
References
Abragamovych OO, Fajura OP, Abragamovych UO. [Comorbidity: a modern look at the problem; clicks (message first)]. L'vivs'kyj klinichnyj visnyk. 2015;1(9):56-64. Ukrainian.
Jelizarova TO, Kuznjecova LV. [Indices of phagocytic activity of monocytes in patients with non-alcoholic steatohepatitis]. Ukrai'ns'kyj morfologichnyj al'manah. 2010;8(4):64-66. Ukrainian.
Zajchenko OE. [Therapeutic targets for non-alcoholic liver disease]. Suchasna gastroenterologіja. 2014;1(75):130-8. Russian.
Plehova NG, Kodrashova NM, Gel'cer BI, Kotel'nikov VN. [Cell-molecular factors of congenital protection and their role in the pathogenesis of pneumonia]. Immunologija. 2017;38(2):124-9. Russian.
MedikVA, Tokmachev MS. [Mathematical statistics in medicine: Textbook. allowance]. Moskva, Finansy i statistika, 2007;800. Russian.
Feshhenko JuІ, Belosludceva KO, Golubovs'ka OA, Gumenjuk MІ. [Untreated pneumonia in adults: etiology, pathogenesis, classification, diagnosis, antibacterial therapy and prevention. A unified protocol for the provision of medical care to adult patients with community-acquired pneumonia]. Nac. akad. med. nauk Ukraїni, 2016;108. Ukrainian.
[Comparative data on the prevalence of respiratory diseases and medical care for patients with pulmonologic and allergic diseases inUkrainefor 2010-2016]. Centr med. statistiki Ukraїni MOZ Ukraїni, 2017;45. Ukrainian.
[About the approval of clinical protocols for the provision of medical care in the specialty "Pulmonology": Order of the Ministry of Health of Ukraine N 128 dated March 19, 2007]. Kyiv, 2007;146. Ukrainian.
SkibchikVA,VojtovichMO.[Non-alcoholic fatty liver disease: modern diagnosis]. Gepatologіja. 2015;1:52-56. Ukrainian.
Frolov VM. [Determination of phagocytic activity of peripheral blood monocytes in patients]. Laboratornoe delo. 1990;9:27-29. Russian.
Chugaj OO, Ljubіnec' LA. [Phagocytic activity of leukocytes in the dynamics of the development of experimental pneumonia]. Svіt medicini ta bіologії. 2017;2(60):172-4. Ukrainian.
Jagmur VB. [Non-alcoholic fatty liver disease: a modern look at pathogenesis, diagnosis and treatment]. Gastroenterologіja. 2013;3(49):138-47. Ukrainian.
AraújoAR, Rosso N, Bedogni G, Tiribelli C, Bellentani S. Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future. Liver Int. 2018;38Suppl1:47-51.
Kolditz M, Ewig S. Community-Acquired Pneumonia in Adults. Dtsch Arztebl Int. 2017;114(49):838-48.
Krenkel O, Tacke F. Macrophages in Nonalcoholic Fatty Liver Disease: A Role Model of Pathogenic Immunometabolism. Semin Liver Dis. 2017;37(3):189-97.
Sookoian S, Pirola CJ. Nonalcoholic Fatty Liver Disease Progresses into Severe NASH when Physiological Mechanisms of Tissue Homeostasis Collapse. Ann Hepatol. 2018;17(2):182-6.
Valderas JM, Sibbald B, Salisbury C. Defining Comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7:357-63.
Waterer GW. Community-acquired Pneumonia: A Global Perspective. Semin Respir Crit Care Med. 2016;37(6):799-805.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2018 Medicni perspektivi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
